Metformin inhibits metastatic breast cancer progression and improves chemosensitivity by inducing vessel normalization via PDGF-B downregulation
Jichang Wang(Shenyang Aerospace University), Peijun Liu(First Affiliated Hospital of Xi'an Jiaotong University)
Cited by 141
Related Papers
Suppression of tumor angiogenesis by metformin treatment<i>via</i>a mechanism linked to targeting of HER2/HIF-1α/VEGF secretion axis
|Oncotarget|2015|107
Simvastatin suppresses the DNA replication licensing factor MCM7 and inhibits the growth of tamoxifen-resistant breast cancer cells
|Scientific Reports|2017|66
miR-367 stimulates Wnt cascade activation through degrading FBXW7 in NSCLC stem cells
|Cell Cycle|2017|51
RETRACTED ARTICLE: Simvastatin and Atorvastatin inhibit DNA replication licensing factor MCM7 and effectively suppress RB-deficient tumors growth
|Cell Death and Disease|2017|45
Breast cancer stem-like cells are sensitized to tamoxifen induction of self-renewal inhibition with enforced Let-7c dependent on Wnt blocking
|International Journal of Molecular Medicine|2018|32